We all have one thing in common: a thirst for knowledge.
We all think outside the box and beyond, or “oltre”…
​
In line with that, our logo is inspired to 'Wanderer above the Sea of Fog' by Friedrich.
​
Guillaume Ploussard, MD PhD
Co-Founder and Chief Executive Officer
​
Guillaume Ploussard is a recognized expert in the field of genito-urinary oncology. He is and has been the principal investigator in several clinical trials in oncology and innovative technologies. For his scientific contributions he holds several editorial positions in prestigious peer-reviewed journals. He has published more than 300 articles, has received several research grants and awards.
​
Bernard Malavaud, MD PhD FEBU
Co-Founder and Chief Strategy Officer
​
​
Bernard Malavaud is Professor and Chair of Urology at the University Comprehensive Cancer Centre "Oncopole" of Toulouse. He has developed translational research in oncology and is co-founder and Board member of SmartCatch, a spinoff of the French National Center for Scientific Research, dedicated to the capture of circulating tumor cells. He serves as a Board member of the European Association of Urology (EAU). He is the 2003 recipient of the prestigious EAU Matula award.
​
Giuseppe Fallara, MD
Co-Founder and Scientific Advisor
​
Giuseppe Fallara is a consultant Urologist at the European Institute of Oncology in Milan. He has extensive knowledge in data mining and big data analysis. He has a deep interest in oncology, and has a solid track record as lead of oncological and population-based studies on andrology. He has worked in cutting edge research centers across Italy, Sweden and the United Kingdom. He is known for delivering on-time and high-quality results through a collaborative and flexible approach.
​
Alberto Martini, MD
Co-Founder and Scientific Advisor
​
Alberto Martini is a fellow in urologic oncology at MD Anderson Cancer Center in Houston, Texas, currently ranked as the #1 cancer center in the world. He has a deep interest in oncological research focusing on addressing relevant clinical problems with innovative and non-conventional methods. His scientific contributions have received major national and international awards. He is an associate member of the EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer and the 2022 recipient of the EAU Hans Marberger Award.